You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:37:10 UTC
Last Updated2019-10-01 21:41:33 UTC
CypComp IDCC02158
Compound Information
NameBDB
Structure ImageVhmrxgaiddcgdu vifpvbqesa n
InChIKeyVHMRXGAIDDCGDU-VIFPVBQESA-N
PubChem ID54579998
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <14,1;Cleavage;R1>
  • <14,2;Cleavage;R1>
  • <14,H;Oxidation;R1>
  • <14,1;Cleavage;R1>
  • <14,2;Cleavage;R1>
  • <14,H;Oxidation;R1>
  • Not Available
  • <14,1;Cleavage;R1>
  • <14,2;Cleavage;R1>
  • <14,H;Oxidation;R1>
References
  1. Meyer MR, Peters FT, Maurer HH: Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicol Lett. 2009 Oct 8;190(1):54-60. doi: 10.1016/j.toxlet.2009.06.866. Epub 2009 Jul 2. [PubMed:19576971 ]
  2. Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. [PubMed:10720722 ]
Download FileCC02158.sdf